Anne Wojcicki and her genetic sequencing company 23andMe are locked in a battle with the FDA. Even though it cant report results to customers right now, Wojcicki isnt letting herself get bogged down in the present. At SXSW 2014 she laid out her vision of the future of preventative medicine — one where affordable genome sequencing comes together with big data.
Comments are closed.
